Topiramate Tablet
Product Images NDC 69097-124

15 FDA label images from Cipla Usa Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 15 technical images submitted to the FDA as part of the official labeling for Topiramate (NDC 69097-124). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Cipla Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Topi (Ccb7a1e4 A3a1 4a0e 8eb0 8086f53e314b 01)

Topi (Ccb7a1e4 A3a1 4a0e 8eb0 8086f53e314b 01)
Chemical structure of Topiramate, the active ingredient shown in the diagram with various functional groups including sulfonamide and ketal moieties.*
FDA Label Image

Topi (Ccb7a1e4 A3a1 4a0e 8eb0 8086f53e314b 02)

Topi (Ccb7a1e4 A3a1 4a0e 8eb0 8086f53e314b 02)
A line graph showing cumulative rates for time to first seizure over a period of 500 days comparing Topiramate 50 mg/day and Topiramate 400 mg/day. The graph depicts two lines, one solid for 50 mg/day and one dotted for 400 mg/day, with cumulative rates on the y-axis and time in days on the x-axis. The graph includes sample sizes (N=234 for 50 mg/day, N=236 for 400 mg/day) and a p-value of 0.0002.*
FDA Label Image

Figure 2: Reduction In 4-week Migraine Headache Frequency(studies 10 And 11 For Adults And Adolescents) (Ccb7a1e4 A3a1 4a0e 8eb0 8086f53e314b 03)

Figure 2: Reduction In 4-week Migraine Headache Frequency(studies 10 And 11 For Adults And Adolescents) (Ccb7a1e4 A3a1 4a0e 8eb0 8086f53e314b 03)
A bar chart comparing the change from baseline to double-blind phase in average weekly migraine per day across different treatment groups: Placebo, Topamax 50 mg/day, Topamax 100 mg/day, and Topamax 200 mg/day. Results are shown for two studies, Study 10 and Study 11, with statistical significance indicated for certain dosage groups.*
FDA Label Image

Topiramate 25mg 60 Tablets (Topiramate 25mg 60s)

Topiramate 25mg 60 Tablets (Topiramate 25mg 60s)
Label for Topiramate Tablets USP 25 mg oral tablets by Cipla USA Inc. The label indicates prescription use only, contains 60 white tablets, and provides storage instructions at controlled room temperature. It includes a barcode, batch overprinting area for serial number, expiry, and lot details, and cautions pharmacists to dispense the enclosed medication guide.*
FDA Label Image

Topiramate 50mg 60tablets (Topiramate 50mg 60s)

Topiramate 50mg 60tablets (Topiramate 50mg 60s)
Topiramate Tablets, USP 50 mg oral tablets packaging label from Cipla USA Inc. The label states prescription use only, includes storage instructions, prescription caution, and pharmacist directions. The package contains 60 light orange tablets, with space for batch overprinting including serial number, expiry date, and lot number. Barcode and manufacturer details are also shown.*
FDA Label Image

Topiramate 100mg 60 Tablets (Topiramate 100mg 60s)

Topiramate 100mg 60 Tablets (Topiramate 100mg 60s)
Topiramate 100 mg oral tablet label from Cipla USA Inc. The label indicates each tablet contains 100 mg Topiramate USP. It includes dosage, storage instructions, a caution to verify prescription, and pharmacist dispensing guidance. The label notes 60 orange tablets per package, lot and expiry information to be overprinted, and manufacturing details from Cipla Ltd., India.*
FDA Label Image

Topiramate 200mg 60 Tablets (Topiramate 200mg 60s)

Topiramate 200mg 60 Tablets (Topiramate 200mg 60s)
Topiramate Tablets USP 200 mg oral tablet label from Cipla USA Inc. Displays prescription-only status, dosing instructions, storage conditions, and packaging details. Contains 60 pink tablets per bottle and includes a barcode, batch overprint area, and caution to verify prescription before dispensing.*
FDA Label Image

Topiramate 25mg 500 Tablets (Topiramate 25mg 500s)

Topiramate 25mg 500 Tablets (Topiramate 25mg 500s)
Label for Topiramate Tablets USP 25 mg by Cipla USA Inc. The label indicates prescription use only, with 500 white tablets in the package. It includes directions about dosage form, storage conditions, protection from moisture, and dispensing instructions, along with a barcode and space for batch overprinting information such as serial number, expiry, and lot.*
FDA Label Image

Topiramate 50mg 500 Tablets (Topiramate 50mg 500s)

Topiramate 50mg 500 Tablets (Topiramate 50mg 500s)
Label for Topiramate Tablets, USP 50 mg by Cipla USA Inc. The label states the strength as 50 mg and dosage form as film-coated tablets. It includes a caution to verify prescription before dispensing and instructs pharmacists to dispense the enclosed Medication Guide. The label shows the NDC number 69097-123-12 and packaging quantity of 500 light orange tablets. Storage instructions and manufacturer details in India and USA are also provided.*
FDA Label Image

Topiramate 100mg 500 Tablets (Topiramate 100mg 500s)

Topiramate 100mg 500 Tablets (Topiramate 100mg 500s)
Topiramate Tablets, USP 100 mg oral tablets label by Cipla USA Inc. The label includes drug strength, NDC number 69097-124-12, and prescription caution notes. It indicates 500 orange tablets per container and provides storage instructions, dosage guidance to see package insert, and manufacturer information from Cipla Ltd., India, with Cipla USA address in New Jersey. A barcode and space for batch overprinting are also present.*
FDA Label Image

Topiramate 200mg 500 Tablets (Topiramate 200mg 500s)

Topiramate 200mg 500 Tablets (Topiramate 200mg 500s)
Label for Topiramate Tablets USP 200 mg by Cipla USA Inc. The label shows the NDC 69097-125-12 and indicates the package contains 500 pink tablets. It includes dosing information, pharmacist instructions, and storage guidelines. Manufactured by Cipla Ltd., India, and labeled for dispensing by Cipla USA Inc., Warren, NJ.*
FDA Label Image

Topiramate 25mg 1000 Tablets (Topiramate 25mg 1000s)

Topiramate 25mg 1000 Tablets (Topiramate 25mg 1000s)
Topiramate Tablets, USP 25 mg label from Cipla USA Inc. The label indicates oral tablets with a strength of 25 mg per film-coated tablet. It includes usage instructions, storage conditions, manufacturer details in India and the USA, a barcode, and space for batch overprinting with serial number, expiration, and lot information. The package specifies 1000 white tablets.*
FDA Label Image

Topiramate 50mg 1000 Tablets (Topiramate 50mg 1000s)

Topiramate 50mg 1000 Tablets (Topiramate 50mg 1000s)
Topiramate Tablets, USP 50 mg tablet label by Cipla USA Inc. The label includes the NDC number 69097-123-15 and instructions for pharmacists to verify the prescription and dispense the enclosed Medication Guide. It specifies storage conditions, manufacturer information, and batch overprinting area for serial number, expiry, and lot. The package contains 1000 light orange tablets.*
FDA Label Image

Topiramate 100mg 1000 Tablets (Topiramate 100mg 1000s)

Topiramate 100mg 1000 Tablets (Topiramate 100mg 1000s)
Label for Topiramate Tablets USP 100 mg by Cipla USA Inc. The label indicates prescription-only status and cautions to verify prescription before dispensing. It includes instructions for pharmacists to dispense the enclosed Medication Guide. The package contains 1000 orange tablets. Storage instructions specify protection from moisture at controlled room temperature (20°C to 25°C). Manufacturer details and a barcode are also present.*
FDA Label Image

Topiramate 200 mg 1000 Tablets (Topiramate 200mg 1000s)

Topiramate 200 mg 1000 Tablets (Topiramate 200mg 1000s)
Topiramate Tablets USP, 200 mg, film-coated tablets in a pink color, in a large bottle containing 1000 tablets. The label includes cautionary text advising pharmacists to verify prescriptions and dispense an enclosed medication guide. Manufactured by Cipla Ltd., India, and labeled for Cipla USA Inc., the label provides storage instructions and notes on packaging.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.